← Open Payments lookup

STUART MILAN: Open Payments

NPI 1689766958 · FLOWOOD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$919 in 41 payments from 9 companies in 2025. Trend: 2023 $473 · 2024 $453 · 2025 $919

Food & beverage: $919
CompanyPaymentsAmount
Axsome Therapeutics, Inc.6$227
ABBVIE INC.14$213
Vanda Pharmaceuticals Inc.8$202
Otsuka America Pharmaceutical, Inc.5$106
Indivior Inc.3$70
Janssen Pharmaceuticals, Inc2$42
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$25
Braeburn Inc.1$18
Supernus Pharmaceuticals, Inc.1$15

Products named: Auvelity, VRAYLAR, FANAPT, REXULTI, SUBLOCADE, SPRAVATO, CAPLYTA, BRIXADI.

Industry payments across MS — which companies pay providers there.